Changes Encourage Celltrion And Nan Fung To Bet On China Biosimilars Opportunity

 
• By Brian Yang
  
Incheon_South Korea_1200x675
INCHEON-BASED CELLTRION SETS UP CHINA BIOSIMILARS JV WITH NAN FUNG • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Focus On Asia